But analysts expect the company to report a loss for the quarter on Thursday, due to lower margins from the acquired stores. Lehman Brothers analyst Meredith Adler rates the stock "Overweight," noting that the acquisition could boost its pricing power. Goldman Sachs analyst John Heinbockel rates it "Neutral," saying CVS Caremark (CVS) looks like the best bet in the industry.
No comments:
Post a Comment